Strategizing Research for Impact.


Journal

HealthcarePapers
ISSN: 1929-6339
Titre abrégé: Healthc Pap
Pays: Canada
ID NLM: 100961305

Informations de publication

Date de publication:
04 2022
Historique:
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 30 6 2022
Statut: ppublish

Résumé

In its Strategic Plan 2021-2026, the Canadian Institutes of Health Research - Institute of Health Services and Policy Research (IHSPR) convincingly expresses its desire to expand capacity for applied health services and policy research (HSPR) and better mobilize research results for health system transformation geared toward the Quadruple Aim and health equity for all (CIHR IHSPR 2021). These strategic priorities echo views widely shared within the HSPR community, and we commend IHSPR for its leadership and vision. Recognizing the systemic challenges ahead of us, this commentary considers the HSPR community's capacity to achieve the promise of learning health systems, given the obstacles likely to hinder their rapid scale-up over the next five years. Next, we consider the spread of virtual care during the pandemic to illustrate the embedded and negotiated nature of innovation in health systems and the need for vigilance as to the social distribution of their benefits and costs. Finally, a critical review of the strategic plan provides insights into how research is governed in the HSPR field. Based on this analysis, it appears essential to reconsider health system transformation as social system transformation and strengthen interdisciplinary and comparative research. Looking forward, developing a science of science to better understand the conditions associated with high-impact research should be a cross-cutting priority for Canada's HSPR community.

Identifiants

pubmed: 35759487
pii: hcpap.2022.26841
doi: 10.12927/hcpap.2022.26841
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-76

Informations de copyright

Copyright © 2022 Longwoods Publishing.

Auteurs

Denis A Roy (DA)

Deputy Commissioner-Evaluation Commissaire à la santé et au Bien-être Quebec City, QC; Assistant Professor, School of Public Health, Université de Montréal, Montreal, QC.

Matthew Menear (M)

Assistant Professor, Department of Family Medicine and Emergency Medicine, Laval University; Researcher, VITAM - Center for Sustainable Health Research, Integrated University Health and Social Services Center, Quebec City, QC.

Hassane Alami (H)

Postdoctoral Researcher, Interdisciplinary Research in Health Sciences, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Jean-Louis Denis (JL)

Professor and Canada Research Chair, Health System Design and Adaptation, School of Public Health, Université de Montréal-CRCHUM-CRDP, Montreal, QC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH